New Alzheimer's drug candidate begins safety testing in healthy volunteers
NCT ID NCT07016464
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tested the safety and tolerability of a new medicine called REM0045392, being developed for Alzheimer's disease. The study involved 19 healthy adults, including younger men and older men and women, who received either the drug or a placebo. The trial was terminated, so full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
REM0045392
What this could lead to
If successful, this could lead to a new treatment option for Alzheimer's disease.
What could go wrong
This is a very early Phase 1 trial in healthy people, not Alzheimer's patients. The study was terminated, so results may be incomplete. Many early-stage drugs fail to show benefit in later trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain Metabolism Study Using PET/fMRI (NCT05756335)
- Short-term arm immobilization & muscle metabolis NCT06750497
- Parent-led app boosts kids' motor & brain skills NCT07680075
- DigiKids App-Based Motor Skills Trial for Kids (NCT07679633)
- QX-4533 Safety Study in Healthy People | NCT07678463
- Pomegranate Supplement & Gut Health in Alcohol L NCT07678567
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Belgium NV - Clinical Pharmacology Unit
Edegem, 2650, Belgium